about
White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathiesWhole exome sequencing coupled with unbiased functional analysis reveals new Hirschsprung disease genes.Pluripotent stem cell for modeling neurological diseases.Hedgehog and Notch signaling in enteric nervous system development.Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.RET and NRG1 interplay in Hirschsprung disease.Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotencyHeterogeneity of neuroblastoma.Potential use of skin-derived precursors (SKPs) in establishing a cell-based treatment model for Hirschsprung's disease.Common genetic variants regulating ADD3 gene expression alter biliary atresia risk.Identification of GLI Mutations in Patients With Hirschsprung Disease That Disrupt Enteric Nervous System Development in Mice.Uncovering the genetic lesions underlying the most severe form of Hirschsprung disease by whole-genome sequencing.Update on the Role of Stem Cells in the Treatment of Hirschsprung Disease.Genome-wide copy number variation study in anorectal malformations.Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenibDual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup MedulloblastomaDysregulation of clathrin promotes thyroid cell growth and contributes to multinodular goiter pathogenesisProkineticin signaling is required for the maintenance of a de novo population of c-KIT⁺ cells to sustain neuroblastoma progressionIdentification of Genes Associated With Hirschsprung Disease, Based on Whole-Genome Sequence Analysis, and Potential Effects on Enteric Nervous System Development
P50
Q26750556-DB9EA375-615C-4CB5-93E4-91CAF002025AQ36301311-3E492FAA-0F55-46FE-8735-2C1120ADCF4DQ38060410-72014A90-DEE4-4607-92E8-351E98C0E5BCQ38172812-A670A612-6F90-4428-80D7-AC314F1554ECQ38710558-56277391-EB20-4EE0-B9A6-72027A981C9BQ39196293-AF160F4A-CAC6-45C0-BC97-E63FEDCD16E6Q39263949-3ECAB4FD-134E-4FF8-9AB5-ABB3C18644E8Q42328309-CCDFA12D-1275-45A2-8875-B9AA619C8F99Q43141028-9360E45A-AAC2-44C9-802C-B9C0B975AF16Q46348278-4281CF33-87F8-4EA1-A372-7633FBCD509EQ47969095-E6853B21-EB7C-4ED1-A607-FAC79AC60174Q50571615-7E74E9C1-4289-4AAB-8DFE-66470136A769Q52372462-EAFD55BE-91FE-4BD5-80F3-BEE1CE122257Q52566599-717BD9B5-C286-478F-99C3-234BD9C2B757Q52631202-5303C148-75CF-490C-9E50-FC4C48E39843Q57233962-C493D453-B5BA-4A25-9708-67F3C4F46722Q59185719-71BE9BD5-19D8-421B-BCA5-9FB0E9369BFBQ63979647-D0633FCB-2EF2-4105-B364-23E7EF5F8CEEQ87322290-C364A765-E9C9-4E58-8228-7869428CA0ADQ87449115-0B0B2D69-4948-4194-9F1E-66789D6499A8Q91456541-0D496F23-A4F6-4F67-9773-8C1CC7344C8B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Elly Sau-Wai Ngan
@en
Elly Sau-Wai Ngan
@nl
type
label
Elly Sau-Wai Ngan
@en
Elly Sau-Wai Ngan
@nl
prefLabel
Elly Sau-Wai Ngan
@en
Elly Sau-Wai Ngan
@nl
P31
P496
0000-0002-0022-7999